MedTrace Logo

Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery

NCT04718116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-02-08

No results posted yet for this study

Summary

The aim of this randomized one-blinded study will be to evaluate the efficacy and tolerability of two different oral doses of tapentadol and compare it to tramadol (an opioid commonly used to treat post-surgical pain) in cardiac surgery patients

Conditions

  • Postoperative Pain
  • Surgery
  • Pain, Postoperative
  • Pain, Acute
  • Pain, Chronic
  • Pain, Procedural
  • Pain, Neuropathic
  • Analgesia

Interventions

DRUG

Group tapentadol 50 mg

patients in group A will receive tapentadol 50 mg p.o 3 times daily for two days

DRUG

group tapentadol 75 mg

patients in group B will receive tapentadol 75 mg p.o 3 times daily for two days

DRUG

group tramadol 100 mg

patients in group C will receive tramadol 100 mg p.o 3 times daily for two days

Sponsors & Collaborators

  • Aretaieion University Hospital

    lead OTHER

Principal Investigators

  • Kassiani Theodoraki, PhD, DESA · Aretaieion University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04718116 on ClinicalTrials.gov